Vice President, Pricing & Market Access
Kymera TherapeuticsWatertown, Massachusetts, United States · Posted 2 months agoDescription
Who we are:
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
How we work:
- PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
- COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
- BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you’ll make an impact:
The Head of Pricing & Market Access will lead global and U.S. pricing, reimbursement, access, and value strategies across Kymera's pipeline and future commercial products. Reporting to the Chief Commercial Officer, this executive will play a critical role in maximizing patient access and commercial value by shaping payer, provider, government, and health-system strategies from late-stage development through launch and lifecycle management.
As a key member of the Commercial Leadership Team, this leader will partner closely with Marketing, Clinical Development, Medical Affairs, Regulatory, HEOR, Market Research, Finance, Business Development, and Corporate Strategy to ensure access considerations are embedded throughout development and commercialization planning.
The ideal candidate will bring deep immunology expertise, preferably including atopic dermatitis and asthma, along with a proven track record of market access leadership across U.S. and global markets.
Pricing Strategy
- Lead global and U.S. pricing strategies across the portfolio, including launch pricing, lifecycle pricing, contracting, and access optimization.
- Develop evidence-based pricing recommendations informed by market dynamics, unmet need, competitive landscapes, and payer insights.
- Oversee pricing governance and provide recommendations to executive leadership and the Board as needed.
- Assess pricing implications of business development opportunities and pipeline investments.
Market Access & Reimbursement
- Develop market access and reimbursement strategies aligned with Kymera's commercialization roadmap, including planned launches in atopic dermatitis and asthma.
- Execute payer and reimbursement strategies to support successful launches and sustained access.
- Establish value propositions and access approaches for Commercial, Medicare, Medicaid, and international markets.
- Lead engagement strategies with U.S. payers, PBMs, integrated delivery networks, and government stakeholders.
Value & Evidence Strategy
- Partner with Clinical Development, Medical Affairs, and HEOR to ensure evidence-generation plans meet payer, HTA, and reimbursement requirements.
- Shape endpoint, outcomes, and real-world evidence strategies that support differentiation and value demonstration.
- Guide development of value dossiers, AMCP materials, economic models, and HTA submissions.
Launch Excellence
- Lead access readiness and launch planning for late-stage programs.
- Develop pricing, access, reimbursement, and uptake assumptions for forecasting.
- Identify and mitigate market access risks throughout development and commercialization.
Leadership & Cross-Functional Influence
- Serve as the company's expert on payer dynamics, healthcare policy, pricing trends, and reimbursement environments.
- Influence enterprise decisions through data-driven insights and strategic recommendations.
- Foster a culture of collaboration, accountability, innovation, and patient focus.
Skills and experience you’ll bring:
- Bachelor's degree required; Advanced degree required (MBA, MPH, PharmD, PhD, MD, or equivalent).
- 15+ years of experience in pharmaceutical or biotechnology market access, pricing, reimbursement, HEOR, or related commercial functions.
- Significant experience developing and executing U.S. and global pricing and market access strategies.
- Demonstrated success leading market access strategy for specialty and/or biologic medicines.
- Immunology therapeutic area experience.
- Deep understanding of U.S. payer systems, PBMs, Medicare, Medicaid, and reimbursement pathways.
- Experience influencing clinical development and evidence-generation strategies to support payer value.
- Experience leading launch preparation and commercialization efforts for innovative specialty medicines.
- Experience interacting with global HTA agencies and ex-U.S. reimbursement bodies.
Leadership & Organizational Capabilities
- Strong executive presence with the ability to influence senior leaders and cross-functional stakeholders.
Similar jobs
Est. 250,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 250,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 200,000 USD
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve…
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 250,000 USD
Position Summary What if... We could harness the power of Flagship’s scientific platforms and create novel treatment options that benefit more patients, sooner? Pioneering Medicines, an initiative of Flagship Pioneering,…
Est. 165,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 140,000 USD
GeneDx (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-s…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 322,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 250,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 165,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 140,000 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 140,000 USD
Beacon Biosignals is transforming precision medicine for the brain, from clinical development to clinical care. For Life Sciences partners, we offer the leading at-home EEG platform for clinical development of novel ther…
Est. 140,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 250,000 USD
About Flagship Pioneering Flagship Pioneering invents and builds companies that change the world. We bring together the greatest scientific minds with entrepreneurial company builders and assemble the capital to allow th…
Est. 182,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 243,000 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 182,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve…
Est. 120,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 140,000 USD
Join Us in Tackling Autoimmune Disease at Its Root At Vor, we believe science can do more than manage symptoms. It can change the course of disease. By advancing telitacicept, a first- and potentially best-in-class dual…
Est. 247,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 140,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 120,000 USD
Company Description Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in ca…